Oncternal Therapeutics, Inc. ONCT
Set alert
0.53 0.00 0.00%
At close · Dec 2
0.5266 Day range 0.70
52-week range unavailable
- Open
- 0.70
- Prev close
- 0.5266
- Mkt cap
- 1.56M
- Vol
- 644.13K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5266
- High
- 0.70
- Forward P/E
- -0.05
- Beta
- 0.00
- Short ratio
- 0.09
- Inst. own
- 12.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2024
- 50-d avg
- 1.06
- 200-d avg
- 5.13
- 1y target
- 2.00
Analyst view
Consensus: hold
Hold
Price target (mean) 2.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -3.47 | -3.47 – -3.47 | -3.11 | -11.6% | 275.00K | -7.4% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -12.43 | -12.43 – -12.43 | -13.43 | +7.4% | 1.92M | +144.6% | 1 |
| Next year | -10.25 | -10.25 – -10.25 | -12.43 | +17.5% | 600.00K | -68.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 15, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 29, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |